Colonization of the Female Urethra With Mycoplasma Hominis, Ureaplasma Urealyticum, Chlamydia Trachomatis, or Neisseria Gonorrhea in Patients With Lower Urinary Tract Symptoms

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2012 by University of Zurich.
Recruitment status was  Not yet recruiting
Sponsor:
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01559623
First received: March 19, 2012
Last updated: March 20, 2012
Last verified: March 2012
  Purpose

The purpose of this study is to assess the prevalence of mycoplasma hominis, ureaplasma urealyticum, neisseria gonorrhea, and chlamydia trachomatis in women with overactive bladder symptoms, and to correlate these findings with cystoscopic and urodynamic findings.


Condition Intervention
Overactive Bladder Syndrome
Procedure: retrospective data analysis

Study Type: Observational
Study Design: Time Perspective: Retrospective

Resource links provided by NLM:


Further study details as provided by University of Zurich:

Estimated Enrollment: 1000
Study Start Date: March 2012
Estimated Study Completion Date: February 2013
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: retrospective data analysis
    retrospective data analysis
  Eligibility

Ages Eligible for Study:   16 Years and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

clinic for urogynecology

Criteria

Inclusion criteria:

  • women with urogynecologic and urodynamic examination at our institution between 1.1.2009 and 31.12.2011

Exclusion criteria:

  • none
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01559623

Contacts
Contact: David Amos Scheiner, MD david.scheiner@usz.ch

Locations
Switzerland
University Hospital Zurich, Gynecology Not yet recruiting
Zurich, ZH, Switzerland, 8091
Sponsors and Collaborators
University of Zurich
Investigators
Principal Investigator: David Amos Scheiner, MD University Hospital Zurich, Division of Gynecology
  More Information

No publications provided

Responsible Party: University of Zurich
ClinicalTrials.gov Identifier: NCT01559623     History of Changes
Other Study ID Numbers: OAB2012
Study First Received: March 19, 2012
Last Updated: March 20, 2012
Health Authority: Switzerland: Swissmedic

Additional relevant MeSH terms:
Urinary Bladder, Overactive
Urinary Bladder Diseases
Urologic Diseases
Urological Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on July 23, 2014